Sunovion gets FDA nod for Kynmobi to treat Parkinson’s disease off episodes

This article was originally published here

The approval enables to use of Kynmobi sublingual film for the acute and intermittent treatment of off episodes in patients with Parkinson’s disease. Kynmobi, a novel formulation of

The post Sunovion gets FDA nod for Kynmobi to treat Parkinson’s disease off episodes appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply